UNICEF price data for
vaccines and injection supplies are publicly available, but data on delivery costs have until recently
been less accessible. (...) Table 3: Assumed injection device parameter values Parameter Value
Injection syringes
Unit price of BCG injection syringe (2020 US$) 0.036
Unit price of 0.5 ml injection syringe (2020 US$) 0.037
Injection syringe wastage 5%
Reconstitution syringes
Unit price of reconstitution syringe (2020 US$) 0.042
Reconstitution syringe wastage 5%
Safety boxes
Unit price of safety box (5 liters) 0.557
Capacity of safety box (no. of syringes) 100
Freight and handling fees
Injection device freight charge 30%
Injection device UNICEF handling fee 8%
7
Delivery costs
Delivery costs, also referred to as operational costs, are defined as costs associated with delivering vaccines exclusive of vaccine costs (Box 1). (...) Costs of vaccine
and injection supplies for a child less than 12 months amounts to US$25.
Language:English
Score: 981617.3
-
https://www.unicef.org/romania...%20a%20Child%20-%20english.pdf
Data Source: un
Select language
Select language
English
South-East Asia
India
Home
Health topics
Our work
News
Emergencies
About us
Home /
News /
Detail /
Punjab first state to introduce injection safety programme
Punjab first state to introduce injection safety programme
10 August 2017
Highlights
At the World Hepatitis Day 2017 event, organized by the Department of Health and Family Welfare, Government of Punjab, the state Action Plan on Injection Safety was launched by Mr Brahm Mohindra, Health Minister, Government of Punjab at Chandigarh on 28 July 2017.
(...) This State Action Plan details key activities to be jointly undertaken by WHO Country Office for India and Government of Punjab as part of WHO’s Injection safety Implementation Project in state of Punjab.
The injection safety project aims to support policy process for adoption of re-use prevention (RUP) syringes in therapeutic care in both, public and private sector; increase awareness about rational use of injections, capacity building of healthcare providers, improve health care waste management practices and step-up overall attention on the quality and safety of healthcare.
Language:English
Score: 977005.1
-
https://www.who.int/india/news...uce-injection-safety-programme
Data Source: un
Methods
This was a prospective non-randomized community intervention trial designed to test the provision of injectable contraceptives by community-based reproductive health agents (CBRHAs). (...) In addition, clients of CBRHAs were less likely to discontinue using injectable contraceptives over three injection cycles than health post clients.
Conclusion
Receiving injectable contraceptives from CBRHAs proved as safe and acceptable to this sample of Ethiopian women as receiving them in health posts from HEWs.
Language:English
Score: 975616.3
-
https://www.who.int/bulletin/volumes/89/8/11-086710-ab/en/
Data Source: un
In Vietnam and Iran, some 50 – 60% of AIDS cases are among injecting drug users and in Russia the figures rise to over 80%.
(...) “Scaling up treatment among injecting drug users is essential to fight HIV and to help stop discrimination among this vulnerable group. (...) Where injecting drug use is a criminal offence, as is the case in many countries, drug users have even more limited or no access to prevention and treatment services.
Language:English
Score: 975616.3
-
https://www.who.int/3by5/newsitem8/en/
Data Source: un
Methods
This was a prospective non-randomized community intervention trial designed to test the provision of injectable contraceptives by community-based reproductive health agents (CBRHAs). (...) The outcomes observed when injectable contraceptives were administered by HEWs in health posts and when they were administered by CBRHAs were compared.
This was a prospective non-randomized community intervention trial designed to test the provision of injectable contraceptives by community-based reproductive health agents (CBRHAs).
Language:English
Score: 974463.2
-
https://www.who.int/reproducti...mily_planning/bulletin89_8/en/
Data Source: un
When used properly, injections save lives. But, many developing countries face barriers. (...) In 2004, 417 000 people died a result of diseases spread through unsafe injection practices. 1
Expanding injection use to family planning, maternal, newborn and child health services would be possible if these problems could be overcome.
(...) “Does a novel prefilled injection device make postpartum oxytocin easier to administer?
Language:English
Score: 972872.3
-
https://www.who.int/pmnch/abou...m/2010_showcase/en/index4.html
Data Source: un
Factors associated with willingness to pay for methadone maintenance treatment (MMT) among HIV-infected Vietnamese patients, by injection drug use (IDU) status html, 8kb
Discussion
This study assessed willingness to pay for MMT among patients with HIV infection in three Vietnamese epicentres of injection-drug-driven HIV infection. (...) This is the first study to report the costs of injection drug use among HIV-infected individuals in Viet Nam. (...) Finally, injection drug users who experienced other types of drug rehabilitation before taking MMT were more willing to pay for treatment and willing to pay a much greater amount than injection drug users with no history of drug rehabilitation.
Language:English
Score: 963865.3
-
https://www.who.int/bulletin/volumes/91/7/12-115147/en/
Data Source: un
Injectable Polio Vaccine (IPV): Flyer | UNICEF Uganda
Skip to main content
Uganda
Toggle navigation
Global Links
Visit UNICEF Global
High contrast
Uganda
Explore UNICEF
Who we are
UNICEF in Uganda
Our representative
Work with us
Press centre
Donate
Main navigation
What we do
Research and reports
Stories
Take action
Search area has closed.
(...) Search Close
Search UNICEF
Fulltext search
Max
Report
Injectable Polio Vaccine (IPV): Flyer
What parents and caregivers need to know
UNICEF Uganda/2012/Ramson
Highlights
The Booklet contains information on the new Injectable Polio Vaccine (IPV).
Author
Ministry of Health, UNICEF, World Health Organisation
Publication date
April 2017
Languages
English
Download
Download file
(PDF, 860,17 KB)
Related topics
Polio
Uganda
More to explore
Report
Injectable Polio Vaccine (IPV): Fact sheet
What you need to know
See the full report
Report
Injectable Polio Vaccine (IPV): Booklet
What parents and caregivers need to know
See the full report
Report
Question and Answer booklet on routine immunization
Learn more about immunization
See the full report
Report
Measles: Question and Answer Booklet for leaders
What leaders need to know and do
See the full report
Footer
UNICEF Home
What we do
Research and reports
Stories
Take action
About us
Press centre
UNICEF in Uganda
Our representative
Work with us
Procurement
Become a donor
Social
Footer Secondary
Contact
Legal
Footer tertiary
Report fraud, abuse, wrongdoing
Language:English
Score: 961590.1
-
https://www.unicef.org/uganda/...ctable-polio-vaccine-ipv-flyer
Data Source: un
Know the risks
WHO is alerting people to the risks of contracting hepatitis from unsafe blood, unsafe injections, and sharing drug-injection equipment. Some 11 million people who inject drugs have hepatitis B or C infection. (...) Eliminating unnecessary injections is also an effective strategy to protect against hepatitis transmission. There are 16 billion injections administered every year. Around 5% of these injections are for immunization, a further 5% for procedures like blood transfusions and injectable contraceptives, and the remaining 90% to administer medicines.
Language:English
Score: 960153.5
-
https://www.who.int/news/item/...rgent-action-to-curb-hepatitis
Data Source: un
OPENING
DATE COMMODITY
VALUE IN USD
AWARDED COMPANY
PURPOSE
RFP-DAN-2017-502502 Clinical Laboratory Supplies Time Bound LTA Fleischhacker GmbH & Co.KG 12 months + 12 months
RFP-DAN-2017-502502 Clinical Laboratory Supplies Time Bound LTA IMRES BV 12 months + 12 months
RFP-DAN-2017-502502 Clinical Laboratory Supplies Time Bound LTA Amex Export Import GmbH 12 months + 12 months
RFP-DAN-2017-502502 Clinical Laboratory Supplies Time Bound LTA VWR International GmbH 12 months + 12 months
RFP-DAN-2019-503099 30.10.2019 Pneumococcal conjugate vaccines 5,597,510.00 Pfizer Inc 2021 to 2025
NA NA Procurement of BiPAP Machine for Afghanistan Country Office 617,499.69 World Health Organization (WHO)
RFP-DAN-2020-503239 09.11.2020 Southern Hemisphere Seasonal Influenza Vaccine 2021 174,000.00 Green Cross Corporation
RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Hindustan Syringes & Medical Devices Ltd. 01.01.2020 to 31.12.2021
RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Amson Vaccines & Pharma (Pvt.) Ltd. 01.01.2020 to 31.12.2022
RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Anhui Tiankang Medical Technology C 01.01.2020 to 31.12.2022
RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value BD International 01.01.2020 to 31.12.2022
RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value KD Medical GmbH Hospital Products 01.01.2020 to 31.12.2022
RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Sanavita Pharmaceuticals GmbH 11.08.2020 to 31.12.2022
RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Smurfit Kappa Sverige AB 01.01.2020 to 31.12.2022
RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Pa Hu Oy 01.08.2020 to 31.12.2022
RFP-DAN-2018-502908 18.12.2018 Freeze-preventive Cold Boxes and Vaccine Carriers Time Bound LTA AOV INTERNATIONAL LLP 24 months + 12 months
RFP-DAN-2018-502908 18.12.2018 Freeze-preventive Cold Boxes and Vaccine Carriers Time Bound LTA Qingdao LEFF International Trading Co., Ltd 24 months + 12 months
RFP-DAN-2018-502908 18.12.2018 Freeze-preventive Cold Boxes and Vaccine Carriers Time Bound LTA 24 months + 12 months
RFP-DAN-2018-502908 18.12.2018 Freeze-preventive Cold Boxes and Vaccine Carriers Time Bound LTA M S NILKAMAL LIMITED
31.08.2021 with possible extension by 12 months
RFP-DAN-2020-503209 25.11.2020 COVID19 Vaccine Time Bound LTA AstraZeneca, AB Sweden 12 months + 12 months
RFP-DAN-2020-503209 25.11.2020 COVID19 Vaccine Time Bound LTA Sinovac Biotech Co., Ltd. 12 months + 12 months
RFP-DAN-2020-503209 25.11.2020 COVID19 Vaccine Time Bound LTA Janssen Pharmaceutica NV 12 months + 12 months
RFP-DAN-2020-503209 25.11.2020 COVID19 Vaccine Time Bound LTA Moderna Switzerland GmbH 12 months + 12 months
RFP-DAN-2017-502553 15.09.2017 Meningococcal ACW polysaccharide vaccine 1,876,081.87 Instituto de Tecnologia em Imunobiologicos Bio Manguinhos 31/12/2021
RFP-DAN-2020-503217 01.10.2020 Yellow Fever Vaccine 49,955,000.00 FSBSI "Chumakov FSC R&D IBP RAS" LTA – 12 months i.e. until 31-12-2021
RFP-DAN-2020-503217 01.10.2020 Yellow Fever Vaccine 4,380,000.00 Institut Pasteur de Dakar LTA – 12 months i.e. until 31-12-2021
RFP-DAN-2020-503217 01.10.2020 Yellow Fever Vaccine 7,680,000.00 Instituto de Tecnologia em Imunobiologicos Bio Manguinhos LTA – 12 months i.e. until 31-12-2021
RFP-DAN-2015-501985 13.04.2015 Oral Cholera Vaccine 38,778,000.00 EuBiologics Co Ltd additional 12 months i.e. until 31-12-2021
RFP-DAN-2015-501985 13.04.2015 Oral Cholera Vaccine 11,100,000.00 Sanofi Healthcare India Private Ltd additional 12 months i.e. until 31-12-2021
Language:English
Score: 958757.8
-
https://www.unicef.org/supply/...20Contract-awards-Jan-2021.pdf
Data Source: un